{"name":"Venatorx Pharmaceuticals, Inc.","slug":"venatorx-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE9idXU3RjBUNHp1eTFJRll6c1E4QVhaVEhHNXNQWmlmQ0F3SXBGc1FCbXo0cGNZVzBFQ3VwTHZZVFZnNGJoU3BwRkkybkVmdDV5eWRVcDhiRXhtQlpZanQwWlJiMGhXdlRIR0JaT0p4TmUxQTFF?oc=5","date":"2026-01-09","type":"pipeline","source":"VISTA.Today","summary":"Malvern-Based Venatorx Pharmaceuticals Scales Down of Operations - VISTA.Today","headline":"Malvern-Based Venatorx Pharmaceuticals Scales Down of Operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPN0VGUkIwRGhaTlVkNTVVX1V0UTRSOHFnX1NsbnFxcE93dUhhSzJCQ1ZoWkFEMGlVa2JpUnpwYnR1a2xrbGJ5MWFVbDZ6OUVXMzMyWVFWQWtObTV0Sk9LZEVrS3VLcXR6UEFWeEdGaDNIcVJOUTlGQ01vTmtNNTNMTzhpZEdEcUZPdEV0ajg4VUdyOW1GbV8tdk5za3o5XzQ?oc=5","date":"2025-12-31","type":"pipeline","source":"The Business Journals","summary":"Venatorx Pharmaceuticals 'winds down' operations with equipment auction - The Business Journals","headline":"Venatorx Pharmaceuticals 'winds down' operations with equipment auction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1fa09EUmNNS0JOVUliaHRGd3Z2aVRzcURTS0J4ZlUyVS1BakE4aFRDazR3c29jMklxNS1WR1NncE1UU3QyOEJPdlByS3ZhNjVfM2tVeVlkQ2g1dmZ1ckZjOGV0YjdtbzdSclFGcFB0bDM?oc=5","date":"2025-09-09","type":"deal","source":"VISTA.Today","summary":"Malvern-Based Venatorx Enters Global Deal with Switzerland Pharma Company - VISTA.Today","headline":"Malvern-Based Venatorx Enters Global Deal with Switzerland Pharma Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPN1NZU21qendzNXRNNXpqNUtoSk5hV3M5UU12emUyaG5aV1pyLU5KR1VCdTlCMGJ6Vi1zWG5lckU2djh5eXNoLUdvZ3d3eUhPZmRubmFjWWctZnFQNFVwQ19FRDJqNG1UZGotaVo2YmNjeVBXdkxPZXhzbE9HRk9ydWxaVWtfZWdGbEZleEREWU1uNUw3cWR4cnJ4Ynd4MVRPOE01SnVTQWwweUJhdWRZZGtn?oc=5","date":"2025-09-04","type":"pipeline","source":"The Business Journals","summary":"Swiss pharma company Basilea bets up to $325M on Venatorx's experimental UTI treatment - The Business Journals","headline":"Swiss pharma company Basilea bets up to $325M on Venatorx's experimental UTI treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPNHdFejVlekRPS0VLd3B2VmNIMG9icHJ0cUpHcGhNdGVXWFNTZFgwS0NCbGtEZmlUdVNRcnBBVFVhLUROU0FJSlhCNE5JVUFXQjNKX1NyX1U2cmxvUzk5dVNqZzZLVUx0dUI1UDZCT2d0enpiY0F5XzBIbG53UGZLV1RfaE5WZDdyNV91MlM0a3YteEE0d3cxWHAtQ3pmWlpsSUk1eHFkUjVES2JUWjNyR2swd00yUQ?oc=5","date":"2025-08-14","type":"pipeline","source":"Pharmaceutical Technology","summary":"Basilea secures rights to Venatorx’s antibiotic for complicated UTIs - Pharmaceutical Technology","headline":"Basilea secures rights to Venatorx’s antibiotic for complicated UTIs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPb2pIMjBLTnJTR2ZoRnBBRjFlbDBWSFFzSG9VREowZkM3cXlZREFENERiOUpSOHFEVklyUHNZbXoyV1lMWmZaV2RtbGlWbTBRSGVDVmppWk83UDBtRmtJeTJVcGxDYzVSOWo5V1JDY3NCUV9WX0JScXFNbDEyX2RQbms4andyUXBSQjNHMnRseWZiRXRmR1lJVHVFZXJNN0ZpbG9oelhCMWFNUnhqbjRCUEJ4TEhxY04xdDV5RkZkbVFHS2lwLW5mRnNIWHU1cXk0UF9yTGhjd2RkMm9TMVBZNk9vV1dONEk?oc=5","date":"2025-08-14","type":"trial","source":"GlobeNewswire","summary":"Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic - GlobeNewswire","headline":"Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQa1RjakJOVkE0bHF0dHRocWRyVWVTb084S1NESU4tV2x3MlBOMTh6Z3RzWU9CUnRDV0NkT3pRck1SUkduWEd3MjlsazZLNzJJaGdYRUs4RTBJY2UxYnh1WHBNRjZCMkpHdTlXN05TTV83M0FQLVBzZkdIeGtJMkVraF9WYW1NRlFpQzk4d29UMnM4VTZRN04ydWdRZHpmRTc0Snpv?oc=5","date":"2025-05-22","type":"pipeline","source":"pharmacytimes.com","summary":"Overcoming Metallo-β-Lactamases: A Review of Cefepime-Taniborbactam - pharmacytimes.com","headline":"Overcoming Metallo-β-Lactamases: A Review of Cefepime-Taniborbactam","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQVi1yc19ld05jTi1ZME5yTS1kdjd3bWFyQWMyZ1lfSndqZm1TQUxWY3pfNndYTVB4VVB4UHJ3OEdYQVcyRjFwT0dlZFlJMi1sMGJCX19xREo5ZDQ1TW42M1FueC1td2Zmclhzb3hnOGIxTUo3ODRVNUFnUnJpV0ExV1NuTURSX3JmeGhpbngzb3BzN2p5WDhqVDE3c1R0am5qNnlWRElhM3k4akoybjF5c25NamRoM0R0c0JESXBXRjY?oc=5","date":"2024-05-16","type":"pipeline","source":"Business Wire","summary":"Venatorx Pharmaceuticals Announces Changes to Executive Leadership - Business Wire","headline":"Venatorx Pharmaceuticals Announces Changes to Executive Leadership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOUEY3ZDBkUXZzazlOTUp6UTRIOEhFdHBGdktTSkxuZUZvaTNCSzlZZ1pxRVZ0cnlwazkzNmRNVVhqU01lZ0RuTjZXNkFiVmZaNk9iM1cwZVlveVpQUEg5OVdKMFZKZ2JIbDFXRHRxLXNXaUFBbFNncjl0eTR6N1ZTZXNZRFA1Yk9GbjNhMXIydm0zUmhabWhsY1RaLWRoMDZhUGpQenprZDctVnlrd3pxYQ?oc=5","date":"2024-02-27","type":"regulatory","source":"Fierce Pharma","summary":"One up, one down: Allecra scores FDA nod for antibiotic combo after Venatorx hit with rejection - Fierce Pharma","headline":"One up, one down: Allecra scores FDA nod for antibiotic combo after Venatorx hit with rejection","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxPYVlVQ1pVUHdMb3dvamZXM0t1SzgySlVNYUIwM3hUdWFZY0YyMFl1MUxWUktpU0pRcnVRaW1NeXI0cEVhM1dIdEUzUHg3UmtQRF9hSzJ3Z2lNMG9jTzc5UVNkU3dHX1NFM0dReEJLVEdGVE9VUTJDb3BYRF9Na1RyNkk5cXpRMUNOMEJqYk13QkVoTno5R3J5M2MtbVA5bC1TRW5HTlZTZ1NEUTZWdnQ1a21oMUVZU1pPNkpOV1FaTGJMUWlGY2hUMEVUMkRLOEtQWFlCbkM3NjlDVExwNGJvMXZHUmVLVzhCYTczdVhSR1BYWG01QjJIaTI2RXBHQU1HQXc?oc=5","date":"2024-01-09","type":"pipeline","source":"PR Newswire","summary":"Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries - PR Newswire","headline":"Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQSUFoZ3dNbkp5aGNxOUczNlFzSjBWV0VURmI1cktwOXU4QVRvSWtkRXhhbkFaQ0ZiZktBMWhTeHJrY015LWRvNDN1eFdKVEQydUI0SGxjZC1jY3RjZGVwM1VremJkTGhXZ2NOOEk2RVV6dFlwb3ZRTS03Yjh5S2ZXc2dFQnRSSUdYQzk1WHdyTGV0RDJQNVhISGFfT3J0MjdpSUZyME1VMlVvUS03ZVVvWE85NmFWZjZPMURIUjBXV2luN1lJ?oc=5","date":"2023-11-11","type":"deal","source":"Contagion Live","summary":"Melinta Therapeutics Partnering with Venatorx Pharmaceuticals on Commercializing Antibiotic - Contagion Live","headline":"Melinta Therapeutics Partnering with Venatorx Pharmaceuticals on Commercializing Antibiotic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOVHBNMVljTVBxOHRCb25waHNpUkt5eEZPWWpnS194T2JMTE1QUENBUGdTYjBScy1nVzRGbGJ5M2pWcHBhMHYtNHN1cEI5OWNfQnk1NFJlb0luT21VVW9uNW5CNnFydUtBQy1GdGNfdFlXSVEyWHNpSndCTXk1clFTVEczMExicFZwLVE?oc=5","date":"2018-08-09","type":"pipeline","source":"BioSpace","summary":"VenatoRx Pharmaceuticals named a 2018 Best Places to Work - BioSpace","headline":"VenatoRx Pharmaceuticals named a 2018 Best Places to Work","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}